首页> 外文期刊>Toxicology Reports >KALGAE? (Klebsormidium flaccidum var. ZIVO) dried algal biomass - 90-day dietary toxicity study and genotoxicity studies
【24h】

KALGAE? (Klebsormidium flaccidum var. ZIVO) dried algal biomass - 90-day dietary toxicity study and genotoxicity studies

机译:卡尔加? (flaclesmidium flaccidum var。ZIVO)干燥藻类生物质-90天的饮食毒性研究和遗传毒性研究

获取原文
           

摘要

Consumers are demanding plant-based alternative protein sources to complement traditional animal-based protein sources to fulfill their dietary protein requirements. KALGAE?, a dried algal biomass derived from Klebsormidium flaccidum var. ZIVO, is a potential source of plant-based protein that has been evaluated for safety to support its use as a food ingredient. There were no treatment-related adverse effects observed in the 14-day palatability/toxicity or 90-day dietary toxicity study in CRL Sprague-Dawley CD? IGS rats. In the 90-day study, KALGAE? was administered to rats in the diet at 0, 37,500, 75,000, or 150,000?ppm. No adverse effects were attributed to the test substance for the following parameters: body weight, body weight gain, mean food consumption and efficiency, hematology, clinical chemistry, urinalysis, gross pathology, histopathology, or organ weights. Although some statistically significant effects were recorded, the effects were not considered to be of toxicological relevance. A No Observable Adverse Effect Level (NOAEL) of 150,000?ppm, equivalent to dietary intakes of 7895.2 (male) and 9708.09 (female) mg KALGAE?/kg body weight/day in rats was established. KALGAE? was non-mutagenic in the in vitro bacterial reverse mutation assay at concentrations up to 5000?μg/plate (with or without S9 metabolic activation), nor was KALGAE? genotoxic in the in vivo mammalian erythrocyte micronucleus test in Swiss albino (ICR) mice. These results support the safe use of KALGAE? as an ingredient in foods.
机译:消费者要求以植物为基础的替代蛋白质来源,以补充传统的基于动物的蛋白质来源,以满足其饮食中的蛋白质需求。 KALGAE 2,一种干燥的藻类生物质,衍生自flaccidum var。 ZIVO是一种潜在的植物性蛋白质来源,已经过安全性评估,可支持其用作食品成分。在CRL Sprague-Dawley CD ? IGS大鼠的14天适口性/毒性或90天饮食毒性研究中未观察到与治疗相关的不良反应。在90天的研究中,卡尔加?在饮食中以0、37,500、75,000或150,000?ppm的剂量对大鼠给药。受试物质在以下参数上没有任何不良影响:体重,体重增加,平均食物消耗和效率,血液学,临床化学,尿液分析,总体病理学,组织病理学或器官重量。尽管记录了一些统计学上显着的影响,但这些影响不被认为具有毒理学意义。在大鼠中建立了150,000?ppm的无可观察到的不良反应水平(NOAEL),相当于饮食摄入量为7895.2(男性)和9708.09(女性)mg KALGAE?/ kg体重/天。卡尔加?在体外细菌反向突变试验中,浓度高达5000μg/板(有或没有S9代谢激活)时是否没有致突变性,KALGAE也没有吗?瑞士白化病(ICR)小鼠体内哺乳动物红细胞微核试验的遗传毒性。这些结果是否支持安全使用KALGAE?作为食品的成分。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号